Your browser doesn't support javascript.
loading
Use of Psychopharmacologic Medications in Adolescents With Restrictive Eating Disorders: Analysis of Data From the National Eating Disorder Quality Improvement Collaborative.
Monge, Maria C; Forman, Sara F; McKenzie, Nicole M; Rosen, David S; Mammel, Kathleen A; Callahan, S Todd; Hehn, Rebecca; Rome, Ellen S; Kapphahn, Cynthia J; Carlson, Jennifer L; Romano, Mary E; Malizio, Joan B; Bravender, Terrill D; Sigel, Eric J; Rouse, Mary R; Graham, Dionne A; Jay, M Susan; Hergenroeder, Albert C; Fisher, Martin M; Golden, Neville H; Woods, Elizabeth R.
Afiliación
  • Monge MC; Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts. Electronic address: mcmonge@seton.org.
  • Forman SF; Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • McKenzie NM; Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Rosen DS; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan.
  • Mammel KA; Division of Adolescent Pediatrics, Beaumont Children's Hospital, Royal Oak, Michigan.
  • Callahan ST; Division of Adolescent Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hehn R; Program for Patient Safety and Quality, Boston Children's Hospital, Boston, Massachusetts.
  • Rome ES; Section of Adolescent Medicine, Department of General Pediatrics, Cleveland Clinic Children's Hospital, Cleveland, Ohio.
  • Kapphahn CJ; Division of Adolescent Medicine, Stanford University School of Medicine, Stanford, California.
  • Carlson JL; Division of Adolescent Medicine, Stanford University School of Medicine, Stanford, California.
  • Romano ME; Division of Adolescent Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Malizio JB; Division of Adolescent Medicine, Steven and Alexandra Cohen Children's Medical Center, North Shore-Long Island Jewish Health System, New Hyde Park, New York.
  • Bravender TD; Department of Pediatrics, The Ohio State University, Columbus, Ohio; Nationwide Children's Hospital, Columbus, Ohio.
  • Sigel EJ; Children's Hospital of Colorado, Section of Adolescent Medicine, University of Colorado, Aurora, Colorado.
  • Rouse MR; Department of Pediatrics, Indiana University School of Medicine, Indiana University Health, Indianapolis, Indiana.
  • Graham DA; Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.
  • Jay MS; Division of Adolescent Medicine, Children's Hospital of Wisconsin, Milwaukee, Wisconsin.
  • Hergenroeder AC; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.
  • Fisher MM; Division of Adolescent Medicine, Steven and Alexandra Cohen Children's Medical Center, North Shore-Long Island Jewish Health System, New Hyde Park, New York; Department of Pediatrics, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York.
  • Golden NH; Division of Adolescent Medicine, Stanford University School of Medicine, Stanford, California.
  • Woods ER; Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts.
J Adolesc Health ; 57(1): 66-72, 2015 Jul.
Article en En | MEDLINE | ID: mdl-26095410
PURPOSE: Psychopharmacologic medications are often prescribed to patients with restrictive eating disorders (EDs), and little is known about the frequency of use in adolescents. We examined the use of psychopharmacologic medications in adolescents referred for treatment of restrictive ED, potential factors associated with their use, and reported psychiatric comorbidities. METHODS: Retrospective data from the initial and 1-year visits were collected for patients referred for evaluation of restrictive ED at 12 adolescent-based ED programs during 2010 (Group 1), including diagnosis, demographic information, body mass index, prior treatment modalities, and psychopharmacologic medications. Additional data regarding patients' comorbid psychiatric conditions and classes of psychopharmacologic medications were obtained from six sites (Group 2). RESULTS: Overall, 635 patients met inclusion criteria and 359 had 1-year follow-up (Group 1). At intake, 20.4% of Group 1 was taking psychopharmacologic medication and 58.7% at 1 year (p ≤ .0001). White, non-Hispanic race (p = .020), and prior higher level of care (p < .0001) were positively associated with medication use at 1 year. Among Group 2 (n = 256), serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors use was most common, and 62.6% had a reported psychiatric comorbidity. Presence of any psychiatric comorbidity was highly associated with medication use; odds ratio, 10.0 (5.6, 18.0). CONCLUSIONS: Adolescents with restrictive ED treated at referral centers have high rates of reported psychopharmacologic medication use and psychiatric comorbidity. As more than half of this referral population were reported to be taking medication, continued investigation is warranted to ensure the desired outcomes of the medications are being met.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psicotrópicos / Anorexia Nerviosa / Trastornos de Ingestión y Alimentación en la Niñez Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Adolesc Health Asunto de la revista: PEDIATRIA Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psicotrópicos / Anorexia Nerviosa / Trastornos de Ingestión y Alimentación en la Niñez Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Adolesc Health Asunto de la revista: PEDIATRIA Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos